Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chul Ahn

Showing results (361-370 of 558) with videos related to

Pageof 56
Sort By:
Journal of Clinical Medicine|February 13, 2020
Application of Fisetin to the Quantitation of Serum AlbuminJung-Min Park, Van Quan Do, Yoon-Seok Seo, et al.
Organic & Biomolecular Chemistry|June 1, 2014
Novel 3-arylethynyl-substituted thieno[3,4-b]pyrazine derivatives as human transglutaminase 2 inhibitorsNayeon Kim, Se Hun Kwak, Seon-Hyeong Lee, et al.
American Journal of Clinical Oncology|April 24, 2020
Stage-specific Conditional Survival Among Young (Age Below 50 y) Versus Older (Age 50 y and Above) Adults With Colorectal Cancer in the United StatesNina N Sanford, Chul Ahn, Muhammad S Beg, et al.
Environmental Geochemistry and Health|April 25, 2019
Exposure assessment for the abandoned metal mine area contaminated by arsenicJun Young Chang, Seung Chul Ahn, Jung Sub Lee, et al.
American Journal of Therapeutics|May 20, 2009
Interhospital transfer of patients with ST-segment elevation myocardial infarction for percutaneous coronary interventionFausan S Tsai, William M Mellana, Wilbert S Aronow, et al.
Journal of Natural Products|January 31, 2019
Prenylated Flavonoids from the Roots and Rhizomes of Sophora tonkinensis and Their Effects on the Expression of Inflammatory Mediators and Proprotein Convertase Subtilisin/Kexin Type 9Jongmin Ahn, Young-Mi Kim, Hee-Sung Chae, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2024
Stereotactic Ablative Radiotherapy for T1 to T2 Glottic Larynx Cancer: Mature Results From the Phase 2 GLoTtic Larynx-SABR TrialDavid J Sher, Vladimir Avkshtol, Dominic Moon, et al.
Cancer Treatment and Research Communications|June 12, 2023
Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in KoreaBeung-Chul Ahn, Seoyoung Lee, Jiyun Lee, et al.
JAMA Network Open|February 16, 2022
A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder CancerMuhammet Ozer, Suleyman Y Goksu, Nina N Sanford, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2023
HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell CarcinomaDominic H Moon, Vladimir Avkshtol, Dat Vo, et al.
Pageof 56

Showing results (361-370 of 558) with videos related to

Sort By:
Pageof 56
Journal of Clinical Medicine|February 13, 2020
Application of Fisetin to the Quantitation of Serum AlbuminJung-Min Park, Van Quan Do, Yoon-Seok Seo, et al.
Organic & Biomolecular Chemistry|June 1, 2014
Novel 3-arylethynyl-substituted thieno[3,4-b]pyrazine derivatives as human transglutaminase 2 inhibitorsNayeon Kim, Se Hun Kwak, Seon-Hyeong Lee, et al.
American Journal of Clinical Oncology|April 24, 2020
Stage-specific Conditional Survival Among Young (Age Below 50 y) Versus Older (Age 50 y and Above) Adults With Colorectal Cancer in the United StatesNina N Sanford, Chul Ahn, Muhammad S Beg, et al.
Environmental Geochemistry and Health|April 25, 2019
Exposure assessment for the abandoned metal mine area contaminated by arsenicJun Young Chang, Seung Chul Ahn, Jung Sub Lee, et al.
American Journal of Therapeutics|May 20, 2009
Interhospital transfer of patients with ST-segment elevation myocardial infarction for percutaneous coronary interventionFausan S Tsai, William M Mellana, Wilbert S Aronow, et al.
Journal of Natural Products|January 31, 2019
Prenylated Flavonoids from the Roots and Rhizomes of Sophora tonkinensis and Their Effects on the Expression of Inflammatory Mediators and Proprotein Convertase Subtilisin/Kexin Type 9Jongmin Ahn, Young-Mi Kim, Hee-Sung Chae, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2024
Stereotactic Ablative Radiotherapy for T1 to T2 Glottic Larynx Cancer: Mature Results From the Phase 2 GLoTtic Larynx-SABR TrialDavid J Sher, Vladimir Avkshtol, Dominic Moon, et al.
Cancer Treatment and Research Communications|June 12, 2023
Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in KoreaBeung-Chul Ahn, Seoyoung Lee, Jiyun Lee, et al.
JAMA Network Open|February 16, 2022
A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder CancerMuhammet Ozer, Suleyman Y Goksu, Nina N Sanford, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2023
HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell CarcinomaDominic H Moon, Vladimir Avkshtol, Dat Vo, et al.
Pageof 56